Zura Bio Limited Class A Ordinary Shares
Symbol: ZURA (NASDAQ)
3.32
▼ (-0.30%) -0.010
Company Description:
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Key Stats
- Today's Open: $3.36
- Today's High: $3.38
- Today's Low: $3.265
- Today's Volume: 89.43K
- Yesterday Close: $3.33
- Yesterday High: $3.3888
- Yesterday Low: $3.15
- Yesterday Volume: 465.78K
- Last Min Volume: 984
- Last Min High: $3.319
- Last Min Low: $3.3
- Last Min VWAP: $3.30037
Company Profile
- Name: Zura Bio Limited Class A Ordinary Shares
- Website: https://www.zurabio.com
- Listed Date: 2023-03-21
- Location: LA JOLLA, CA
- Market Status: Active
- CIK Number: 0001855644
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $221.06M
- Round Lot: 100
- Outstanding Shares: 65.02M
- Asset Type: CS
RECENT FILINGS FOR ZURA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-10 | 8-K | View |
| 2025-09-30 | 8-K | View |
| 2025-09-04 | 8-K | View |
| 2025-08-20 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 3 | View |
| 2025-07-16 | SCHEDULE 13G | View |
| 2025-07-01 | 8-K | View |
| 2025-06-04 | 8-K | View |
| 2025-06-03 | UPLOAD | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 3 | View |
| 2025-05-28 | SCHEDULE 13D | View |
| 2025-05-28 | 3 | View |
| 2025-05-27 | 8-K | View |
| 2025-05-23 | 8-K | View |
Latest News on ZURA